Anatomopathological staging of feline hypertrophic cardiomyopathy through quantitative evaluation based on

I Biasato1, L Francescone2, G La Rosa3

  • 1Department of Veterinary Sciences, University of Turin, Grugliasco (TO), Italy.

Insights

This study introduces a repeatable method for quantitatively assessing feline hypertrophic cardiomyopathy (HCM) in cats. It reveals that advanced HCM stages involve left ventricular dilation, left atrial enlargement, and increased coronary arteriosclerosis.

Area of Science:

  • Veterinary Pathology
  • Cardiovascular Pathology
  • Feline Medicine

Background:

  • Feline hypertrophic cardiomyopathy (HCM) is a common cardiac disease in cats.
  • Clinical and anatomopathological diagnoses are crucial for HCM.
  • Standardized echocardiography aids HCM diagnosis and classification.

Purpose of the Study:

  • To provide an original, complete, and repeatable quantitative anatomopathological evaluation of feline HCM.
  • To investigate the temporal evolution of end-stage feline hypertrophic cardiomyopathy (ES-HCM).

Main Methods:

  • Morphometric and histopathological investigations were performed on 21 feline hearts with suspected or diagnosed HCM and 6 control hearts.
  • A quantitative assessment of gross and histopathological features of HCM was developed.

Main Results:

  • The developed quantitative assessment method for HCM features is original and repeatable.
  • Progression to end-stage HCM phenotypes correlates with increased left ventricular fibrous tissue deposition.
  • Advancement to end-stage HCM is associated with left ventricular lumen dilation (P=0.0004), left atrium dilation (P=0.0017), and increased intramural coronary arteriosclerosis (P=0.0293).

Conclusions:

  • A novel, repeatable quantitative method for assessing feline HCM pathology has been established.
  • The study elucidates key pathological changes during the temporal evolution of feline HCM.
  • Findings highlight the progression of HCM towards end-stage phenotypes involving cardiac chamber dilation and vascular changes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
602